Impact of C-reactive protein levels on lipoprotein(a)-associated aortic stenosis incidence and progression.

Arnaud GirardEmilie GaillardRishi PuriRomain CapouladeKwan L ChanAudrey PaulinHasanga D ManikpurageJean DumesnilJames W TamKoon K TeoChristian CoutureNicholas J WarehamMarie-Annick Clavel Erik S G Stroes Patrick Mathieu Sébastien ThériaultSotirios TsimikasPhillippe Pibarot S Matthijs Boekholdt Benoit J Arsenault

Published in: European heart journal open (2023)

Lp(a) predicts the incidence and possibly progression of CAVS regardless of plasma CRP levels. Lowering Lp(a) levels may warrant further investigation in the prevention and treatment of CAVS, regardless of systemic inflammation.

Keyphrases

aortic stenosis
risk factors
ejection fraction
transcatheter aortic valve replacement
aortic valve
transcatheter aortic valve implantation
aortic valve replacement
coronary artery disease
heart failure
combination therapy